Juncture Wealth Strategies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,701
Closed -$396K 108
2022
Q1
$396K Sell
10,701
-2,610
-20% -$102K 0.19% 89
2021
Q4
$605K Sell
13,311
-1,458
-10% -$76.1K 0.29% 68
2021
Q3
$936K Buy
14,769
+1,422
+11% +$108K 0.49% 41
2021
Q2
$1.03M Sell
13,347
-1,611
-11% -$128K 0.59% 35
2021
Q1
$942K Sell
14,958
-2,032
-12% -$158K 0.59% 40
2020
Q4
$1.23M Sell
16,990
-2,918
-15% -$169K 0.78% 29
2020
Q3
$755K Buy
19,908
+340
+2% +$11.5K 0.52% 45
2020
Q2
$693K Sell
19,568
-239
-1% -$6.8K 0.52% 47
2020
Q1
$432K Sell
19,807
-788
-4% -$17.7K 0.4% 59
2019
Q4
$444K Buy
20,595
+1,610
+8% +$36.9K 0.35% 73
2019
Q3
$429K Buy
+18,985
New +$526K 0.38% 67

Other funds holding CDNA

Juncture Wealth Strategies's CDNA Position: Q2 2022 in Review

Juncture Wealth Strategies sold out of CareDx (CDNA) in Q2 2022, closing a stake of 10,701 shares — an estimated $396K sold.

Juncture Wealth Strategies first reported a position in CDNA in Q3 2019 and held it in 11 quarters. The position peaked at $1.23M in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Juncture Wealth Strategies reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Juncture Wealth Strategies sold 10,701 CareDx shares in Q2 2022, an estimated $396K.
  • Juncture Wealth Strategies first reported a position in CareDx in Q3 2019 and held it in 11 quarters.
  • Juncture Wealth Strategies's CareDx position peaked at $1.23M in Q4 2020.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Juncture Wealth Strategies's 13F filing for Q2 2022, filed 14 Jul 2022.